Stay up to date with the latest in healthcare. Our blog delivers trusted medical news, expert insights, and policy updates — helping industry professionals stay informed about 340B
The 340B Drug Pricing Program faces mounting pressure from multiple directions as we head into fall 2025. Recent developments signal that covered entities must take proactive steps to protect their programs and prepare for potential changes.
To say the healthcare policy landscape is fluid would be a massive understatement. Ongoing debates over federal spending, Medicaid eligibility, and safety-net funding have created unprecedented uncertainty for 340B covered entities.